EA200600138A1 - Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов - Google Patents

Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов

Info

Publication number
EA200600138A1
EA200600138A1 EA200600138A EA200600138A EA200600138A1 EA 200600138 A1 EA200600138 A1 EA 200600138A1 EA 200600138 A EA200600138 A EA 200600138A EA 200600138 A EA200600138 A EA 200600138A EA 200600138 A1 EA200600138 A1 EA 200600138A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibitor
crystalline polymorph
obtaining crystalline
aggregation
aggregation inhibitor
Prior art date
Application number
EA200600138A
Other languages
English (en)
Other versions
EA010684B1 (ru
Inventor
Петер Котаи Надь
Дьюла Шимиг
Йожеф Баркоци
Тамаш Грегор
Бела Фаркаш
Дьёрдь Верецкеине Донат
Кальман Надь
Дьюлане Кёртвейэшши
Жужанна Сент-Кирайи
Original Assignee
Эгиш Дьёдьсердьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0302028A external-priority patent/HU0302028D0/hu
Priority claimed from HU0401272A external-priority patent/HU226773B1/hu
Application filed by Эгиш Дьёдьсердьяр Рт. filed Critical Эгиш Дьёдьсердьяр Рт.
Publication of EA200600138A1 publication Critical patent/EA200600138A1/ru
Publication of EA010684B1 publication Critical patent/EA010684B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Настоящее изобретение относится к новому способу получения полиморфной формы 1 метил (S)-(+)-(2-хлорфенил)-2-(6,7-дигидро-4Н-тиено[3,2-с]пиридин-5-ил-ацетата гидросульфата формулы (I).
EA200600138A 2003-07-02 2004-06-30 Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов EA010684B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0302028A HU0302028D0 (en) 2003-07-02 2003-07-02 Process for the production of crystalline polymorphous form of an anticoagulant agent
HU0401272A HU226773B1 (en) 2004-06-23 2004-06-23 Process for the production of clopidogrel hydrogensulfate polymorph 1
PCT/HU2004/000070 WO2005003139A1 (en) 2003-07-02 2004-06-30 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug

Publications (2)

Publication Number Publication Date
EA200600138A1 true EA200600138A1 (ru) 2006-08-25
EA010684B1 EA010684B1 (ru) 2008-10-30

Family

ID=89985327

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600138A EA010684B1 (ru) 2003-07-02 2004-06-30 Способ получения кристаллического полиморфа ингибитора агрегации тромбоцитов

Country Status (14)

Country Link
US (1) US20070142637A1 (ru)
EP (1) EP1644381B1 (ru)
JP (1) JP4681545B2 (ru)
KR (1) KR101155679B1 (ru)
CN (1) CN1812993B (ru)
AT (1) ATE461201T1 (ru)
BG (1) BG109429A (ru)
CA (1) CA2530449C (ru)
CZ (1) CZ200641A3 (ru)
DE (1) DE602004026059D1 (ru)
EA (1) EA010684B1 (ru)
PL (2) PL378710A1 (ru)
SK (1) SK50102006A3 (ru)
WO (1) WO2005003139A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7999106B2 (en) 2004-04-19 2011-08-16 Krka, Tovarna Zdravil, D.D., Novo Mesto Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form I
EP1902058A2 (en) 2005-07-12 2008-03-26 RPG Life Sciences Limited A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
WO2011010318A1 (en) * 2009-07-23 2011-01-27 Praveen Laboratories Private Limited Process for the preparation of clopidogrel polymorphous form 1 using seed chrystals
CN102070648A (zh) * 2010-12-07 2011-05-25 天津红日药业股份有限公司 I型硫酸氢氯吡格雷的制备方法
CN102702224A (zh) * 2012-06-25 2012-10-03 山东齐都药业有限公司 I型硫酸氢氯吡格雷的制备方法
CN107337683B (zh) * 2017-08-16 2019-08-16 中荣凯特（北京）生物科技有限公司 一种噻吩并吡啶类衍生物硫酸氢盐的晶型ⅱ及其制备方法和应用
CN113121559B (zh) * 2019-12-31 2023-08-29 惠州信立泰药业有限公司 一种高堆密度的ii型硫酸氢氯吡格雷球形结晶及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
CN100338068C (zh) * 2001-01-24 2007-09-19 卡地拉健康护理有限公司 制备氯吡格雷的方法
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
ES2316650T3 (es) * 2001-12-18 2009-04-16 Teva Pharmaceutical Industries Ltd. Polimorfos de hidrogenosulfato de clopidogrel.

Also Published As

Publication number Publication date
JP2007516167A (ja) 2007-06-21
CZ200641A3 (cs) 2006-05-17
CN1812993A (zh) 2006-08-02
CA2530449A1 (en) 2005-01-13
EP1644381B1 (en) 2010-03-17
WO2005003139A1 (en) 2005-01-13
US20070142637A1 (en) 2007-06-21
KR101155679B1 (ko) 2012-06-13
CA2530449C (en) 2010-03-23
BG109429A (en) 2006-10-31
PL378710A1 (pl) 2006-05-15
KR20060026119A (ko) 2006-03-22
EP1644381A1 (en) 2006-04-12
JP4681545B2 (ja) 2011-05-11
CN1812993B (zh) 2011-06-29
ATE461201T1 (de) 2010-04-15
EA010684B1 (ru) 2008-10-30
PL1644381T3 (pl) 2010-08-31
SK50102006A3 (sk) 2006-05-04
DE602004026059D1 (de) 2010-04-29

Similar Documents

Publication Publication Date Title
EA200800886A1 (ru) Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов
EA200400491A1 (ru) Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции
RS53292B (en) CRYSTAL FORMS 2-THIAZOLYL-4-HINOLINYL-OXY DERIVATIVES, POWERFUL HCV INHIBITOR
NO20054669L (no) Substituerte kinobenzoxazinanaloger
EA200702670A1 (ru) Препарат тиенопиридинового ингибитора агрегации тромбоцитов
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
EA200401025A1 (ru) Полиморфы клопидогреля и их применение в качестве антитромботических соединений
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
TW200420541A (en) Crystalline forms
BG109429A (en) A METHOD FOR OBTAINING A CRYSTAL POLYMORPHIC FORMAN FOR INHIBITING TROMBOCYTE AGGREGATION
TW200635905A (en) Processes for producing 4-aminoquinazolines
TW200612959A (en) Method for preparing hydroxamic acids
EA200870038A1 (ru) Способ получения аминов
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
WO2005005394A3 (en) Thiophenylaminoimidazolines as prostaglandin i2 antagonists
AR056805A1 (es) Un proceso para oxidacion para la preparcion de n- (3- amino-1- ( ciclobutilmetil) -2,3- dioxopropil ) -3-(n-(( ter-butilamino) carbonil )-3- metil- l- valil) -6,6- dimetil-3- azabiciclo (3.1.0) hexano -2- carboxamida y compuestos ralacionados
EA200800200A1 (ru) Способ получения кристаллического периндоприла
NO20052197L (no) Fremgangsmate for fremstilling av pyrazol
EA200501527A1 (ru) Способ получения полиморфа малеата розиглитазона
CY1112457T1 (el) Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων
WO2005054175A3 (en) New process for the preparation of nitrooxyderivatives of paracetamol
BG109428A (en) METHOD FOR OBTAINING AMORPHIC FORM OF MEDICINES INHIBITION OF THERAPEUTIC AGGREGATION

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU